BR9910401A - New formulation containing paroxetine - Google Patents

New formulation containing paroxetine

Info

Publication number
BR9910401A
BR9910401A BR9910401-6A BR9910401A BR9910401A BR 9910401 A BR9910401 A BR 9910401A BR 9910401 A BR9910401 A BR 9910401A BR 9910401 A BR9910401 A BR 9910401A
Authority
BR
Brazil
Prior art keywords
formulation containing
new formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
BR9910401-6A
Other languages
Portuguese (pt)
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9910401A publication Critical patent/BR9910401A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"NOVA FORMULAçãO CONTENDO PAROXETINA" Hidrocloreto de paroxetina, em uma forma outra que o hemihidrato, que é formulado na forma de cápsulas sob condições tais que não existe conversão detectável para o hemihidrato durante o processo de tabletagem."NEW FORMULATION CONTAINING PAROXETINE" Paroxetine hydrochloride, in a form other than the hemihydrate, which is formulated in the form of capsules under conditions such that there is no detectable conversion to the hemihydrate during the tableting process.

BR9910401-6A 1998-05-13 1999-05-13 New formulation containing paroxetine BR9910401A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
BR9910401A true BR9910401A (en) 2001-01-09

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910401-6A BR9910401A (en) 1998-05-13 1999-05-13 New formulation containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (en)
JP (1) JP2002514591A (en)
KR (1) KR20010043574A (en)
CN (1) CN1308521A (en)
AP (1) AP2000002019A0 (en)
AU (1) AU3940999A (en)
BG (1) BG105010A (en)
BR (1) BR9910401A (en)
CA (1) CA2331871A1 (en)
EA (1) EA200001174A1 (en)
GB (1) GB9810181D0 (en)
HU (1) HUP0102064A2 (en)
ID (1) ID28019A (en)
IL (1) IL139594A0 (en)
NO (1) NO20005683L (en)
PL (1) PL344573A1 (en)
SK (1) SK17142000A3 (en)
TR (1) TR200003350T2 (en)
WO (1) WO1999058113A2 (en)
ZA (1) ZA200006562B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
PT1440067E (en) * 2001-10-22 2005-02-28 Synthon Bv N-FORMYL PAROXETINE DERIVATIVES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EA002034B1 (en) * 1997-01-15 2001-12-24 Смитклайн Бичам Плс Paroxetine compositions
WO1999032092A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets

Also Published As

Publication number Publication date
PL344573A1 (en) 2001-11-05
JP2002514591A (en) 2002-05-21
WO1999058113A2 (en) 1999-11-18
GB9810181D0 (en) 1998-07-08
TR200003350T2 (en) 2001-03-21
WO1999058113A3 (en) 2000-02-17
EP1077682A2 (en) 2001-02-28
AU3940999A (en) 1999-11-29
BG105010A (en) 2001-07-31
NO20005683L (en) 2000-12-05
CA2331871A1 (en) 1999-11-18
AP2000002019A0 (en) 2000-12-31
IL139594A0 (en) 2002-02-10
HUP0102064A2 (en) 2002-05-29
SK17142000A3 (en) 2001-06-11
ID28019A (en) 2001-05-03
CN1308521A (en) 2001-08-15
EA200001174A1 (en) 2001-06-25
KR20010043574A (en) 2001-05-25
ZA200006562B (en) 2002-02-13
NO20005683D0 (en) 2000-11-10

Similar Documents

Publication Publication Date Title
DK0941218T3 (en) Antithrombotic organic nitrates
DE69813922D1 (en) Compositions containing hydroxycarboxylic acid or retinoid
ES2043625T3 (en) ARILOXICARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE.
BR9203707A (en) COMPOUNDS, COMPOSITION, USE OF COMPOUNDS, PROCESS FOR PHOTOPOLIMERIZATION OF COMPOUNDS AND USE OF A COMPOSITION
BR9806296A (en) Sulfic acid derivatives and their preparation and use
YU56995A (en) ONLY DERIVED INDOLA
ID27652A (en) AMIDA DEMONSTRATIONS USED AS A SITOKINA PRODUCTION INHIBITOR
BRPI9815772A (en) use of alkyl hydrogen fumarates for the treatment of psoriasis, psoriatic arthritis, neurodermatitis and regional crohn's enteritis
ES2022239B3 (en) USE OF SILICATES IN LAYERS, SYNTHETICS, ABSORBENTS, IN AQUEOUS TREATMENT COMPOSITIONS, FOR PERFORATIONS.
BR9811099A (en) Urokinase inhibitors
ES2196190T3 (en) INHIBITORS OF METALOPROTEINASAS MATRICIALES, WITH BIFENLICO HYDROXAMATE.
BR9810163A (en) Compounds or their compositions
BR9611263A (en) Cleaning pad for toilet.
BR0109542A (en) Alkylated imidazopyrine derivatives
BR9808140A (en) Unit formulation
BR9910445A (en) Pharmaceutical preparation
BR9910402A (en) New formulation containing paroxetine
ES2043863T3 (en) PROCEDURE FOR PREPARING 1,2,5,6-TETRAHYDROPYRIDINE DERIVATIVES.
BR0014461A (en) Compound and method for preparing the same
NO304885B1 (en) Nipectoin acid derivatives as antithrombotic compounds
NO972887D0 (en) Piperidinedacetic acid derivatives useful as fibrinogen antagonist agent
BR9806321A (en) Process and composition to inhibit polymerization during anaerobic styrene production.
BR9713159A (en) Substantially solid composition, compound, substantially solid salt composition, mixture, and, process for preparing a compound
NO922167D0 (en) AMINODECTS AS CORROSION INHIBITORS
BR9910401A (en) New formulation containing paroxetine

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]